Lallo, A. (2018). The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationLallo, A. The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationLallo, A. The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.